Osteoporosis causes bones to weaken and break more easily. Calcium and phosphorus are two
minerals that are essential for normal bone formation. Unfortunately, calcium salts commonly
prescribed in anti-osteoporosis treatment bind phosphorus from food and restrict phosphorus
available for bone building. Teriparatide is a drug that reduces the risk of fractures by
increasing bone thickness and strength. Vitamin D is also necessary for strong bones and
teeth. The purpose of this study is to evaluate the bone-building effectiveness of two
calcium supplements, one with a source of phosphorus and one without, in combination with
teriparatide and vitamin D in women with osteoporosis.
Phase:
Phase 2
Details
Lead Sponsor:
Creighton University
Collaborators:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Office of Dietary Supplements (ODS)
Treatments:
Calcium Calcium Carbonate Calcium, Dietary Ergocalciferols Teriparatide Vitamin D Vitamins